Elevance Health, Inc. (NYSE:ELV) Receives $565.82 Consensus Price Target from Brokerages
Elevance Health, Inc. (NYSE:ELV – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month price […]
More Stories
ICU Medical (NASDAQ:ICUI) PT Raised to $198.00
ICU Medical (NASDAQ:ICUI – Free Report) had its price target upped by KeyCorp from $147.00 to $198.00 in a report...
Jasper Therapeutics (NASDAQ:JSPR) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated their buy rating on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report released...
Monster Beverage (NASDAQ:MNST) Price Target Raised to $57.00 at Bank of America
Monster Beverage (NASDAQ:MNST – Free Report) had its price target increased by Bank of America from $56.00 to $57.00 in...
BNP Paribas Upgrades Stora Enso Oyj (OTCMKTS:SEOAY) to “Hold”
BNP Paribas upgraded shares of Stora Enso Oyj (OTCMKTS:SEOAY – Free Report) to a hold rating in a research report...
Hut 8 Corp. (NASDAQ:HUT) Receives $16.50 Consensus Target Price from Analysts
Hut 8 Corp. (NASDAQ:HUT – Get Free Report) has been given an average rating of “Buy” by the six brokerages...
Bank of America Increases Vertiv (NYSE:VRT) Price Target to $130.00
Vertiv (NYSE:VRT – Free Report) had its price target hoisted by Bank of America from $115.00 to $130.00 in a...